Replies to post #223666 on Biotech Values

[DewDiligence]

ICPT selling $460M* of stock and convertible debt on unspecified terms:

https://www.globenewswire.com/news-release/2019/05/08/1819739/0/en/Intercept-Pharmaceuticals-Announces-Proposed-Offerings-of-200-Million-of-Common-Stock-and-200-Million-of-Convertible-Senior-Notes-due-2026.html

*Assuming exercise of underwriter’s options (plural).

[DewDiligence]

ICPT submits NDA for Ocaliva/25mg in NASH:

https://www.globenewswire.com/news-release/2019/09/27/1922072/0/en/Intercept-Submits-New-Drug-Application-to-the-U-S-FDA-for-Obeticholic-Acid-in-Patients-with-Fibrosis-Due-to-NASH.html